Introduction
Tuberculosis is a serious infection in the post-transplant period and can have protean manifestations. The incidence of tuberculosis in transplant patients ranges from 0.35% to 15%. 1 Empyema necessitans is not uncommonly seen in patients with pulmonary tuberculosis. Isolated empyema necessitans without active pulmonary tuberculosis in a renal transplant recipient is even rarer and has not been reported previously.
Case report
A 62-year-old gentleman with end stage renal disease (ESRD) secondary to diabetic and hypertensive nephropathy underwent live related ABO compatible transplant in 2007. He had a past history of pulmonary tuberculosis for which he received 6-month anti-tubercular therapy (ATT) in 2006. He was on regular immunosuppression (cyclosporine, mycophenolate mofetil and prednisolone) and had a nadir serum creatinine of 0.9 mg/dL. Early post-transplant period was uneventful and the patient was in regular follow-up. In June 2013, he presented with complaints of low-grade fever and left-sided chest pain for 1 month. On evaluation with chest radiograph, he was found to have left-sided minimal pleural effusion. Sputum smear was negative for acid fast bacilli (AFB). Pleural fluid was positive for AFB. He was started on modified ATT (isoniazid, pyrazinamide, levofloxacin, and ethambutol) and had partial response with decrease in the size of lung consolidation by $50%. In March 2015, the patient developed rise in serum creatinine to 1.69 mg/dL with nephritic range proteinuria. Graft biopsy was suggestive of diabetic kidney disease with chronic calcineurin inhibitor toxicity. In August 2015, the patient noticed a swelling in the left side of the chest associated with lowgrade fever and dyspnea on exertion. On examination, the patient had a fluctuant swelling in the left lower chest opposite to the 8th-11th ribs without associated signs of inflammation. Bilateral scattered wheeze was present on auscultation.
Hematological profile revealed hemoglobin of 8.1 g/dL, white cell count of 4.7 Â 10 9 /L, platelet count of 80 Â 10 9 /L, and a serum creatinine of 2.13 mg/dL. Sputum analysis revealed growth of aspergillus. Staining and culture for mycobacterium tuberculosis were negative. Chest X-ray showed a well-circumscribed opacity in the left lower zone. Ultrasound chest revealed a well-defined cystic lesion in the left posterolateral thoracic wall measuring 8.5 cm Â 5 cm with internal echoes. The lesion was seen to Empyema necessitans is a rare sequel of untreated pleural space infection and is most commonly secondary to tuberculosis. Isolated tuberculous empyema necessitans in a renal transplant recipient is extremely rare. It is an important differential diagnosis of a chest mass in renal transplant recipient. Early identification and treatment prevents progression and morbidity. We hereby report a 62-year-old male renal transplant recipient who presented with classical features of tubercular empyema necessitans and was managed with antitubercular therapy and tube thoracostomy drainage.
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communicate with another collection in the pleural cavity measuring 7.6 cm Â 2.2 cm. After explaining the risk and benefits of iodinated contrast, a contrast-enhanced CT thorax was done which revealed a heterogeneous pleural collection measuring 12.7 cm Â 6.4 cm with surrounding enhancing thickened pleura (Split pleura sign) along the left lower lobe. It was communicating with a similar collection measuring 7.1 cm Â 3.3 cm in the subcutaneous region suggestive of empyema necessitans (Fig. 1 ). Both lungs were normal in appearance. No obvious bony abnormality was found. The patient was continued on ATT and was treated with antibiotics and antifungals (caspofungin and fluconazole) for lower respiratory tract infection. Intercostal drain (ICD) was placed in the left lower thoracic collection through the communication with the subcutaneous collection and 400 mL pus was drained. Pus was negative for AFB (microscopy and culture). However, Gene XpertMtb analysis of the pus revealed Mycobacterium tuberculosis with low level of rifampicin resistance. Rifabutin was introduced but the patient did not tolerate and it was hence stopped. The patient improved symptomatically on 15th day ICD was removed after it was draining less than 5 mL for three consecutive days.During the course of treatment, the patient developed progressive graft dysfunction and was declared ESRD and started on maintenance haemodialysis.
Discussion
Tuberculosis is a global health problem that has affected mankind for more than 4000 years. 2 Tuberculosis is a serious infection in solid organ transplant recipients where the prevalence is 14 times greater than in the general population. 3 The incidence of tuberculosis among renal transplant recipients ranges from 0.35% to 5.00% in the west to around 5-15% in the Indian subcontinent. Lungs are the most common site for post-transplant tuberculosis. 1 The major risk factors for tuberculosis in a post-transplant patient are chronic liver disease (1.7 times), diabetes mellitus (2.2 times), other co-existing infections (2.4 times), particularly deep mycosis, pneumocystis pneumonia, nocardia, and CMV infection. 4 Cyclosporine use advances the onset of the disease. Our patient had a combination of risk factors including diabetes, co-existing aspergillus respiratory tract infection, and cyclosporine use.
Empyema necessitans is a rare complication of untreated pleural space infection where the infected fluid spontaneously dissects into the chest wall from the pleural space. It is a very rare complication in the present era of efficient antibiotics. Tuberculosis is the most common etiology followed by actinomycosis. 5 The natural history is typically long which correlates with the slow progression of these lesions. The most common site of extension is the anterior chest wall because the lung is more adherent to the pleura posteriorly. 6 Other sites of extension include mediastinum, diaphragm, and retroperitoneum. Isolated Empyema necessitans in a renal transplant recipient has never been reported previously. Our patient had a posterior chest mass which is an unusual site of presentation of an empyema necessitans.
Empyema necessitans is known to present as a recurrent swelling and is characteristically known for its paucity of symptoms. Diagnosis of empyema necessitans is made radiographically. Contrast-enhanced CT is the most sensitive modality in differentiating pleural fluid from pleural thickening and for identifying focal pleural or chest wall abnormalities. The split pleura sign in CT results from fibrin coating both the parietal and visceral surfaces of the pleura with resulting ingrowth of blood vessels and accompanying enhancement. It is considered the most reliable sign helping to distinguish an empyema from a peripheral pulmonary abscess. 7 The primary therapeutic aim of treatment of empyema is 'ubi pus evacua' -if you find pus remove it. When an empyema is suspected, thoracocentesis with a large bore needle is indicated. Drainage performed as a single procedure is usually the first line intervention. 8 The efficacy of drainage may be improved by using cyclic or continuous drainage. If tube thoracostomy fails, a video assisted thoracoscopic surgical (VATS) evacuation should be done. Our patient underwent tube thoracostomy drainage along with adjunctive antimicrobial and antifungal therapy. Early identification and treatment of empyema necessitans prevents progression and associated morbidity. Hence, empyema necessitans should be kept in mind when evaluating post-transplant patients presenting with a chest mass especially with a past history of tuberculosis.
Conclusion
Tuberculosis is an important infection in the post-transplant period. Empyema necessitans is an unusual presentation of pulmonary tuberculosis. It should be considered when evaluating post-transplant patients presenting with chest mass, especially with a past history of tuberculosis. With appropriate antitubercular therapy and drainage of the pus, early recovery can be achieved.
